EMA Says Delays In Trulicity Production Have Led To Delays In The Release Of Some Orders
Portfolio Pulse from Happy Mohamed
The European Medicines Agency (EMA) has reported delays in the production of Trulicity, which have subsequently led to delays in the release of some orders.
August 28, 2023 | 2:48 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Eli Lilly and Company (LLY), the producer of Trulicity, may experience short-term stock volatility due to production and order release delays.
Eli Lilly and Company, as the producer of Trulicity, is directly impacted by the production delays. This could lead to potential revenue losses and customer dissatisfaction, which may negatively affect the company's stock price in the short term.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100